查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413918

ELISpot 和 FluoroSpot 檢測市場：按產品、應用和最終用戶 - 2024-2030 年全球預測

ELISpot & FluoroSpot Assay Market by Product (Acessories, Analyzers, Assay Kits), Application (Autoimmune Disorders, Infectious Diseases, Oncology), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2023 年 ELISpot 和 FluoroSpot 檢測市場規模為 2.9268 億美元，2024 年將達到 3.1361 億美元，2030 年將達到 4.7074 億美元，複合年成長率為 7.02%。

ELISpot 和 FluoroSpot 檢測的全球市場

主要市場統計
基準年[2023] 2.9268億美元
預測年份 [2024] 31361萬美元
預測年份 [2030] 47074萬美元
複合年成長率（%） 7.02%
ELISpot & FluoroSpot 檢測市場-IMG1

ELISpot（酵素結合免疫吸附點）測定是一種靈敏且強大的免疫檢測，透過評估細胞激素分泌細胞的數量來測量細胞激素特異性T 細胞的數量。 FluoroSpot 檢測可以視覺化並計算多功能 T 細胞和單一細胞激素產生細胞的數量。 FluoroSpot 檢測使用不重疊的螢光標記細胞激素區分個體和共同分泌的細胞激素。 ELISPOT 和 luminousSpot 檢測均廣泛用於臨床試驗中的免疫監測，其中需要單細胞層級的定量資訊和 T 細胞表現型的鑑定。世界各地慢性病盛行率的上升和生物醫學研究的激增，需要引入強大的免疫學檢測方法進行診斷和監測。此外，由於對個人化醫療的興趣日益濃厚，對製藥和生技領域的投資增加也擴大了這些測定的應用範圍。然而，檢測操作的複雜性和測試結果的可變性阻礙了該檢測的普及。此外，解釋測試結果的困難以及 ELISpot 和 FluoroSpot 檢測資料分析的複雜性進一步使 ELISpot 和 FluoroSpot 的使用變得複雜。然而，醫療保健產業繼續推動技術創新，再加上旨在提高檢測特異性和準確性的研發舉措，以克服使用 ELISpot 和 FluoroSpot 檢測的技術限制。隨著人們對癌症和其他疾病免疫療法的日益關注，對 ELISpot 和 FluoroSpot 檢測的需求持續成長。

區域洞察

ELISpot 和 FluoroSpot 檢測在美洲地區的持續成長是由成熟的醫療保健和生物技術產業、研發方面的大量投資以及主要市場參與者的存在所推動的。尤其是美國，由於其強大的醫療基礎設施和不斷成長的醫療支出，正在引領該地區的成長。歐洲也是 ELISpot 和 FluoroSpot 檢測的關鍵地區之一，德國、英國、法國和義大利等國家引領了該技術的發展。歐洲的成長是由其先進的醫療保健系統和完善的研究機構所推動的。此外，學術機構和產業之間的合作正在推動檢測開發的創新。歐洲市場也受益於旨在開發先進 ELISpot 和 FluoroSpot 檢測的支持性監管政策。在亞太地區，由於人們對先進免疫診斷技術的認知不斷提高，對慢性病的認知不斷提高，以及政府旨在改善醫療保健結果的舉措，對 ELISpot 和 FluoroSpot 檢測的需求不斷成長。此外，該地區 CRO（委外研發機構）的存在使亞太地區成為這兩種檢測方法發展的關鍵地區。

FPNV定位矩陣

FPNV 定位矩陣對於評估 ELISpot 和 FluoroSpot 偵測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 ELISpot 和 FluoroSpot 分析市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-ELISpot 和 FluoroSpot 檢測市場的市場規模和預測是多少？

2-在 ELISpot 和 FluoroSpot 分析市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-ELISpot 和 FluoroSpot 檢測市場的技術趨勢和法律規範是什麼？

4-ELISpot 和 FluoroSpot 偵測市場主要供應商的市場佔有率是多少？

5-進入 ELISpot 和 FluoroSpot 檢測市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病及感染疾病率增加
      • 對免疫療法和個人化醫療的需求不斷成長
      • 由於免疫監測研究的增加，使用量增加
    • 抑制因素
      • 檢測方案的複雜性和可變性
    • 機會
      • 使用者友善高通量檢測系統的開發進展
      • ELISpot 和 FluoroSpot 檢測在獸醫應用中的巨大潛力
    • 任務
      • eLISpot 和 FluoroSpot 偵測解釋和資料分析的複雜性
  • 市場區隔分析
    • 產品：增加研究機構和實驗室對綜合檢測套件的支持
    • 應用：擴大政府努力推動腫瘤學研究、診斷和治療
    • 最終用戶：ELISpot 和 FluoroSpot 檢測在研究和臨床實踐中的相關使用提供了前所未有的精確度和可靠的結果。
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第 6 章 ELISpot 和 FluoroSpot 檢測市場：按產品

  • 配件
  • 分析儀
  • 檢測套件

第 7 章 ELISpot 與 FluoroSpot 偵測市場：按應用分類

  • 自體免疫疾病
  • 感染疾病
  • 腫瘤學
  • 器官移植
  • 疫苗開發

第 8 章 ELISpot 和 FluoroSpot 檢測市場：按最終用戶分類

  • 學術研究所
  • 醫院和臨床實驗室

第9章美洲ELISpot與FluoroSpot分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區ELISpot與FluoroSpot分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的ELISpot和FluoroSpot分析市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第13章競爭產品組合

  • 主要公司簡介
    • Abcam PLC
    • Abnova Corporation
    • Agilent Technologies, Inc.
    • Anogen-Yes Biotech Laboratories Ltd
    • Autoimmun Diagnostika GmbH
    • Becton, Dickinson and Company
    • Bio-Techne Corporation
    • BIOSYS Scientific Devices GmbH
    • BOC Sciences
    • Broughton Life Sciences Limited
    • CellCarta Biosciences Inc.
    • Creative Proteomics
    • Elabscience
    • Full Moon BioSystems, Inc.
    • Jackson ImmunoResearch Inc.
    • Mabtech AB
    • Merck KGaA
    • Oxford Immunotec USA, Inc.
    • Oy Medix Biochemica Ab
    • ProImmune Ltd.
    • Quansys Biosciences Inc.
    • SBH Sciences
    • U-CyTech BV
    • ZenBio, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-961BA04A2DFB

[184 Pages Report] The ELISpot & FluoroSpot Assay Market size was estimated at USD 292.68 million in 2023 and expected to reach USD 313.61 million in 2024, at a CAGR 7.02% to reach USD 470.74 million by 2030.

Global ELISpot & FluoroSpot Assay Market

KEY MARKET STATISTICS
Base Year [2023] USD 292.68 million
Estimated Year [2024] USD 313.61 million
Forecast Year [2030] USD 470.74 million
CAGR (%) 7.02%
ELISpot & FluoroSpot Assay Market - IMG1

ELISpot (enzyme-linked immunosorbent spot) assays are sensitive and potent immunoassays that measure the quantity of antigen-specific T cells by evaluating the number of cytokine-secreting cells. FluoroSpot assays can visualize and enumerate the number of polyfunctional T cells and single-cytokine producers. FluoroSpot assay uses fluorescent labels with discrete, non-overlapping wavelengths to differentiate individual cytokines and co-secreted cytokines. Both ELISPOT and fluoroSpot assays are widely used in immuno-monitoring of clinical trials where both quantitative information and T cell phenotype identification at a single cell level are required. The rising increasing prevalence of chronic diseases across the world and a surge in biomedical research have necessitated the deployment of robust immunological assays for diagnosis and monitoring. Furthermore, the rise in investments in the pharmaceutical and biotechnology sectors, driven by a growing focus on personalized medicine, has expanded the application scope of these assays. However, the complexity of operating the assay and the chances of variability in test results impede the widespread adoption of the assays. Additionally, the difficulty of interpretation of test results and data analysis complexities with ELISpot & FluoroSpot assays further pose complications for utilization of ELISpot and FluoroSpot. However, the healthcare industry's continuous push toward innovation coupled with R&D initiatives aimed towards improving the specificity and accuracy of the assays can overcome the technical constraints of using ELISpot and FluoroSpot assay. A growing emphasis on immunotherapy treatments for cancer and other diseases further creates a significant need for ELISpot and FluoroSpot assays.

Regional Insights

The continued growth of ELISpot and FluoroSpot assays in the Americas region can be credited to its well-established healthcare and biotechnological sectors, significant investments in research and development, and the presence of major market players. Particularly, the United States, with a robust healthcare infrastructure and increased healthcare spending, is driving the growth in this region. Europe is another key region for the ELISpot and FluoroSpot assays, with countries such as Germany, the United Kingdom, France, and Italy leading the growth of the technology. The growth in Europe is driven by advanced healthcare systems and the presence of reputed research institutions. Moreover, collaborations between academic institutions and the industry foster innovation in assay development. The European market also benefits from supportive regulatory policies aimed towards the development of advanced ELISpot and FluoroSpot assays. In the APAC region, the need for ELISpot and FluoroSpot assays is expanding due to increased awareness regarding advanced immunodiagnostic techniques, increased awareness about chronic diseases, and government initiatives aimed at enhancing healthcare outcomes. Furthermore, the presence of contract research organizations (CROs) in this region positions the Asia Pacific as a prominent region for the growth of both assays.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ELISpot & FluoroSpot Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ELISpot & FluoroSpot Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ELISpot & FluoroSpot Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Anogen-Yes Biotech Laboratories Ltd, Autoimmun Diagnostika GmbH, Becton, Dickinson and Company, Bio-Techne Corporation, BIOSYS Scientific Devices GmbH, BOC Sciences, Broughton Life Sciences Limited, CellCarta Biosciences Inc., Creative Proteomics, Elabscience, Full Moon BioSystems, Inc., Jackson ImmunoResearch Inc., Mabtech AB, Merck KGaA, Oxford Immunotec USA, Inc., Oy Medix Biochemica Ab, ProImmune Ltd., Quansys Biosciences Inc., SBH Sciences, U-CyTech BV, and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the ELISpot & FluoroSpot Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Acessories
    • Analyzers
    • Assay Kits
  • Application
    • Autoimmune Disorders
    • Infectious Diseases
    • Oncology
    • Organ Transplantation
    • Vaccine Development
  • End-User
    • Academic Research Institutes
    • Hospitals & Clinical Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the ELISpot & FluoroSpot Assay Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the ELISpot & FluoroSpot Assay Market?

3. What are the technology trends and regulatory frameworks in the ELISpot & FluoroSpot Assay Market?

4. What is the market share of the leading vendors in the ELISpot & FluoroSpot Assay Market?

5. Which modes and strategic moves are suitable for entering the ELISpot & FluoroSpot Assay Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. ELISpot & FluoroSpot Assay Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising need for immunotherapy and personalized medicines
      • 5.1.1.3. Growing usage owing to an increase in immune monitoring studies
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity and variability of assay protocols
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the development of user-friendly and high-throughput assay systems
      • 5.1.3.2. High potential of eLISpot & fluoroSpot assay in veterinary applications
    • 5.1.4. Challenges
      • 5.1.4.1. Interpretation and data analysis complexities with eLISpot & fluoroSpot assays
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing preference for comprehensive assay kits among research institutions and laboratories
    • 5.2.2. Application: Expanding government initiatives to propel oncology research, diagnosis, and therapy
    • 5.2.3. End-user: Pertaining use of ELISpot & FluoroSpot assays in research and clinical practices providing unprecedented accuracy and reliable results
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. ELISpot & FluoroSpot Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Acessories
  • 6.3. Analyzers
  • 6.4. Assay Kits

7. ELISpot & FluoroSpot Assay Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disorders
  • 7.3. Infectious Diseases
  • 7.4. Oncology
  • 7.5. Organ Transplantation
  • 7.6. Vaccine Development

8. ELISpot & FluoroSpot Assay Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Hospitals & Clinical Laboratories

9. Americas ELISpot & FluoroSpot Assay Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific ELISpot & FluoroSpot Assay Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa ELISpot & FluoroSpot Assay Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. New Product Launch & Enhancement
      • 12.3.1.1. Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular and Cell Biology Testing
    • 12.3.2. Investment & Funding
      • 12.3.2.1. Singamaneni to develop advanced protein imaging method
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abcam PLC
    • 13.1.2. Abnova Corporation
    • 13.1.3. Agilent Technologies, Inc.
    • 13.1.4. Anogen-Yes Biotech Laboratories Ltd
    • 13.1.5. Autoimmun Diagnostika GmbH
    • 13.1.6. Becton, Dickinson and Company
    • 13.1.7. Bio-Techne Corporation
    • 13.1.8. BIOSYS Scientific Devices GmbH
    • 13.1.9. BOC Sciences
    • 13.1.10. Broughton Life Sciences Limited
    • 13.1.11. CellCarta Biosciences Inc.
    • 13.1.12. Creative Proteomics
    • 13.1.13. Elabscience
    • 13.1.14. Full Moon BioSystems, Inc.
    • 13.1.15. Jackson ImmunoResearch Inc.
    • 13.1.16. Mabtech AB
    • 13.1.17. Merck KGaA
    • 13.1.18. Oxford Immunotec USA, Inc.
    • 13.1.19. Oy Medix Biochemica Ab
    • 13.1.20. ProImmune Ltd.
    • 13.1.21. Quansys Biosciences Inc.
    • 13.1.22. SBH Sciences
    • 13.1.23. U-CyTech BV
    • 13.1.24. ZenBio, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ELISPOT & FLUOROSPOT ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ELISPOT & FLUOROSPOT ASSAY MARKET DYNAMICS
  • FIGURE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ELISPOT & FLUOROSPOT ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ELISPOT & FLUOROSPOT ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ELISPOT & FLUOROSPOT ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 146. ELISPOT & FLUOROSPOT ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ELISPOT & FLUOROSPOT ASSAY MARKET LICENSE & PRICING